Abciximab Completed Phase 4 Trials for Ischaemia / Coronary Artery Disease (CAD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00169819EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study